Technolas GmbH Perfect Vision: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Technolas GmbH Perfect Vision”, plus 1 PMA decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LZS | Excimer Laser System | 1 | 0 |
Review panels
- Ophthalmic (1)
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P970056 | PMA | BAUSCH & LOMB KERACOR 116 EXCIMER LASER SYSTEM | 1999-09-28 |
Recalls
openFDA lists no recalls under a recalling firm named Technolas GmbH Perfect Vision.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Technolas Perfect Vision GmbH (10 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Technolas GmbH Perfect Vision?
FDA lists 0 510(k) clearances under the applicant name “Technolas GmbH Perfect Vision”, plus 1 PMA decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Technolas GmbH Perfect Vision?
The most frequent FDA product codes under this applicant name are LZS (Excimer Laser System, 1).
Next steps
- See all 0 Technolas GmbH Perfect Vision clearances with predicates and recalls
- Run predicate analysis for product code LZS, Technolas GmbH Perfect Vision's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.